Developer docs
API playgroundTry for free, no card

Search company profiles

OneOncology

Full company profile

uuid0000x3i

Namestring
OneOncology
Legal namestring
OneOncology, LLC
Websiteurl
oneoncology.com
Company typeenum
Private
Founded yearint
2018
Descriptiontext

OneOncology is a physician-led Management Services Organization (MSO) platform that partners with independent oncology, urology, and radiation oncology practices across the United States. Founded in 2018 and headquartered in Nashville, Tennessee, the company aggregates 33 partner practices spanning 350+ sites of care and approximately 2,000 providers serving roughly one million patients. OneOncology enables partner practices to maintain clinical autonomy and physician ownership while gaining access to enterprise-scale technology, capital, operational infrastructure, and clinical resources. The company was acquired by Cencora in early 2026 at a $7.4 billion enterprise value.

The platform comprises multiple integrated modules including OneAnalytics (business intelligence across clinical, operational, and financial data), OneR (clinical research site management organization with 15 active practices running 92 trials in 2025), ProMPT (EMR-nested precision medicine decision support), Oncology Quality Hub (CMS-approved Qualified Clinical Data Registry), ASCO-certified Clinical Pathways, OneCommunity (knowledge sharing), and a recently launched AI strategy layer featuring Agentic AI for prior authorization automation, Databricks-powered RWE analytics, and AI-enabled patient experience capabilities. The technology stack integrates with OncoEMR and is differentiated by domain specialization in oncology rather than horizontal healthcare IT.

OneOncology operates a managed services revenue model through partnership arrangements with physician practices, generating revenue from MSO service agreements customized by practice size and scope. The company does not publicly disclose pricing or revenue figures. Go-to-market is enterprise field sales targeting physician leaders of independent practices seeking operational support and growth capital while preserving clinical autonomy. Key customer segments include independent oncology practices (primary), independent urology practices (post-UUG acquisition), and indirectly the community-based cancer patients served by partner practices across all major US regions.

Short descriptiontext

OneOncology is a physician-led management services organization platform partnering with 33 independent oncology and urology practices across 350+ US sites, serving one million patients with shared technology, analytics, capital, and clinical research infrastructure.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1,001–5,000
akta.pro rankint
HeadquartersNashville, United States
HQ citystring
Nashville
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
oncology practice management, urology practice management, clinical decision support, medical specialty analytics, community oncology network
Industry3 codes
1Ambulatory Oncology Centers (Outpatient Chemo/Radiation)
CodeHLAFABAIPrimaryYes
2Medical Oncology
CodeHLAKAFABPrimaryNo
3Primary Care Networks, Groups & MSOs
CodeHLAFAGAEPrimaryNo
NAICS code2 codes
  • Offices of Physicians62111
  • Ambulatory Health Care Services621
SIC code3 codes
  • Services-Offices & Clinics Of Doctors Of Medicine8011
  • Services-Specialty Outpatient Facilities, Nec8093
  • Services-Health Services8000
Product category
Oncology Practice Management Services
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Management Services Organization (MSO)
TypeManaged Services
Description

OneOncology operates as an MSO providing non-clinical administrative and management support to independent medical specialty practices, including oncology and urology. Revenue is generated through partnership arrangements with physician practices that maintain clinical autonomy while gaining access to platform resources, technology, capital, and operational support.

oneoncology.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 3 records shown
1Oncology Quality Hub
Description

CMS-approved Qualified Clinical Data Registry (QCDR) platform that supports partner practices in achieving MIPS performance and quality reporting requirements.

oneoncology.com
+2 more records
Core offering1 text field

OneOncology is a Management Services Organization (MSO) that partners with independent oncology and urology practices to provide non-clinical administrative, operational, technology, capital, and clinical support while physicians retain clinical autonomy. The platform delivers shared technology, analytics, clinical pathways, research network access, pharmacy and laboratory services, and back-office functions to community-based specialty practices across the United States.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Research network with 15 practices active, 92 trials activated in 2025, 260% increase in trial accruals
+2 more records
Product overview1 text field

OneOncology is a physician-led MSO (Management Services Organization) platform for independent medical specialty practices in oncology, urology, and radiation oncology. The platform operates as a unified ecosystem combining the core OneOncology Platform with multiple integrated modules: OneAnalytics for business intelligence, OneR for clinical research management, Oncology Quality Hub for CMS QCDR compliance and MIPS reporting, ProMPT for precision medicine, Pathways for clinical decision support, OneCommunity for knowledge sharing, and OneCouncil for physician governance. The platform also encompasses acquired brands including United Urology Group, Navigating Care (patient portal), and SunState Medical Specialists. AI capabilities are embedded throughout including patient experience automation, fax intelligence, prior authorization automation, and Databricks-powered analytics.

Product and service11 records
1OneOncology Platform
CategoryCore Platform
Description

Physician-led national platform providing equity partnership arrangements, clinical resources, technology, capital, and operational support to independent oncology and urology practices while preserving physician clinical autonomy.

2OneAnalytics
CategoryAnalytics Module
Description

Analytics platform pulling from multiple systems to measure financial, operational, and clinical performance, providing user-friendly interfaces for physicians and practice leaders to interact with the data warehouse.

3OneR (OneOncology Research Network)
CategoryResearch Services
Description

Clinical research site management organization providing program management, study start-up, contracts and budgets, regulatory, study operations, research finance, research technology, quality, and network site management for community oncology practices.

4Oncology Quality Hub
CategoryQuality Reporting
Description

CMS-approved Qualified Clinical Data Registry providing data-driven insights, clinical quality improvement, value-based care program participation, MIPS performance tracking, and CMS data submission for partner practices.

5ProMPT (Provider Messaging for Precision Therapies)
CategoryClinical Decision Support
Description

Precision medicine tool nested in the EMR that helps physicians interpret next-generation sequencing results, view patient testing reports, explore matching FDA-approved precision therapy options, and obtain precision medicine team support at point of care.

6Clinical Pathways
CategoryClinical Decision Support
Description

ASCO-certified clinical decision support tools driving evidence-based standardized care, clinical trial prioritization, adherence tracking, and informing strategic initiatives with payors around prior authorizations and value-based contracts.

7United Urology Group
CategoryAcquired Brand / Subsidiary
Description

Urology management services organization supporting over 250 providers delivering urology care, genitourinary cancer treatment, radiation oncology, pathology, imaging, and pharmacy services.

8SunState Medical Specialists
CategoryAcquired Brand / Subsidiary
Description

Multi-specialty physician group (formerly GenesisCare USA) with over 100 physicians across urology, oncology, and surgical specialties at 104 clinics in Florida, providing advanced radiation therapies, in-house pharmacy and laboratory, interventional radiology, theranostics, and diagnostic imaging.

9Navigating Care
CategoryPatient Engagement
Description

Patient portal and care management platform supporting integrated patient engagement and care coordination for partner practices.

10OneOncology HIE Integration
CategoryHealth IT Integration
Description

ONC Health IT certified Health Information Exchange integration supporting EMR data exchange with OncoEMR across healthcare systems.

11AI Strategy Platform
CategoryAI Capabilities
Description

AI-powered capabilities including patient experience automation, fax intelligence with EMR integration, agentic AI for drug prior authorization, ProMPT decision analytics, and Databricks-powered data abstraction and clinical trial matching.

Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-10-08
Description

OneOncology acquired GenesisCare USA of Florida and relaunched it as SunState Medical Specialists with 100+ physicians across 104 clinics. The acquisition includes plans for investments in advanced clinical services, technology, and expanding access to specialized care in Florida.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-08-20
Description

United Urology Group, a urology management services organization supporting approximately 250 physicians, partnered with OneOncology in October 2024. The partnership aims to improve urology and cancer care, focusing on complex genitourinary cancers including prostate and bladder cancers. UUG operates as a subsidiary of OneOncology, with CEO Ian Wong transitioning to OneOncology COO.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Physician-centric MSO/value-based care platform serving independent primary care and specialty groups with delegated risk arrangements — comparable MSO structure, capital-light partnership model, and value-based care orientation across diverse specialties.

TypeDirect peer
Description

Physician-group enablement platform partnering with primary care groups under global capitation; comparable capital-light, MSO-style partnership model providing technology, analytics, and payer contracting infrastructure to independent practices.

TypeBroad incumbent
Description

Senior-focused integrated care platform with growing oncology and senior primary care offerings including CenterWell Senior Primary Care and specialty pharmacy — broader incumbent increasingly moving into community oncology and value-based cancer care delivery.

TypeBroad incumbent
Description

Owner of US Oncology Network and one of the largest pharma distributors in the US — broad incumbent that competes head-to-head with OneOncology for community oncology practices and offers parallel drug-distribution economics post-OneOncology's Cencora acquisition.

TypeDirect peer
Description

One of the largest independent community oncology practices in the US, also operates its own research institute and has historically pursued vertical integration including in-house pharmacy and lab — a peer model for large-scale community oncology delivery.

TypeEmerging player
Description

Value-based oncology navigation and care management startup partnering with payers and providers to coordinate cancer care — overlaps with OneOncology's patient navigation, care management, and value-based contract strategy on a smaller, earlier-stage scale.

TypeDirect peer
Description

Specialty care value-based care enabler with explicit oncology, cardiology, and musculoskeletal programs serving independent practices and payers — directly comparable in specialty VBC enablement and clinical pathway infrastructure for oncology.

8The US Oncology Network (McKesson)
TypeDirect peer
Description

McKesson subsidiary operating the largest US network of community oncology practices with comparable practice partnership MSO economics, technology stack, clinical pathways, and research services — OneOncology's closest and most direct competitor for both partner practices and pharma research dollars.

TypeDirect peer
Description

Public physician-enablement MSO platform that partners with independent medical groups across specialties to provide technology, analytics, and population health infrastructure — comparable business model of equity-light, MSO-led multi-specialty practice partnership at scale.

10ION Solutions (Cencora)
TypeOthers
Description

Cencora subsidiary providing group purchasing, technology, and practice support services to community oncology practices — sits inside OneOncology's parent and represents an adjacent oncology practice enablement ecosystem rather than a head-to-head competitor.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat7 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers10 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration2 records

Each record includes

Title, Type, Description, Source

AI capability7 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles12 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries2 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A2 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

OneOncology

Oncology Practice Management Servicesoneoncology.com

OneOncology is a physician-led management services organization platform partnering with 33 independent oncology and urology practices across 350+ US sites, serving one million patients with shared technology, analytics, capital, and clinical research infrastructure.

What OneOncology does

OneOncology is a physician-led Management Services Organization (MSO) platform that partners with independent oncology, urology, and radiation oncology practices across the United States. Founded in 2018 and headquartered in Nashville, Tennessee, the company aggregates 33 partner practices spanning 350+ sites of care and approximately 2,000 providers serving roughly one million patients. OneOncology enables partner practices to maintain clinical autonomy and physician ownership while gaining access to enterprise-scale technology, capital, operational infrastructure, and clinical resources. The company was acquired by Cencora in early 2026 at a $7.4 billion enterprise value.

The platform comprises multiple integrated modules including OneAnalytics (business intelligence across clinical, operational, and financial data), OneR (clinical research site management organization with 15 active practices running 92 trials in 2025), ProMPT (EMR-nested precision medicine decision support), Oncology Quality Hub (CMS-approved Qualified Clinical Data Registry), ASCO-certified Clinical Pathways, OneCommunity (knowledge sharing), and a recently launched AI strategy layer featuring Agentic AI for prior authorization automation, Databricks-powered RWE analytics, and AI-enabled patient experience capabilities. The technology stack integrates with OncoEMR and is differentiated by domain specialization in oncology rather than horizontal healthcare IT.

OneOncology operates a managed services revenue model through partnership arrangements with physician practices, generating revenue from MSO service agreements customized by practice size and scope. The company does not publicly disclose pricing or revenue figures. Go-to-market is enterprise field sales targeting physician leaders of independent practices seeking operational support and growth capital while preserving clinical autonomy. Key customer segments include independent oncology practices (primary), independent urology practices (post-UUG acquisition), and indirectly the community-based cancer patients served by partner practices across all major US regions.

OneOncology firmographics

Firmographics
Name
OneOncology
Legal name
OneOncology, LLC
Website
https://oneoncology.com
Company type
Private
Founded year
2018
Operating status
Operating
Headcount range
1,001–5,000 employees
Short description
OneOncology is a physician-led management services organization platform partnering with 33 independent oncology and urology practices across 350+ US sites, serving one million patients with shared technology, analytics, capital, and clinical research infrastructure.
Ownership category
akta.pro rank

OneOncology industry classification

Industry
Product category
Oncology Practice Management Services
NAICS
Offices of Physicians (62111), Ambulatory Health Care Services (621)
SIC
Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Specialty Outpatient Facilities, Nec (8093), Services-Health Services (8000)
akta.pro primary industry
Ambulatory Oncology Centers (Outpatient Chemo/Radiation) (HLAFABAI)
akta.pro secondary industries
Medical Oncology (HLAKAFAB), Primary Care Networks, Groups & MSOs (HLAFAGAE)

Keywords

  • Oncology practice management
  • Urology practice management
  • Clinical decision support
  • Medical specialty analytics
  • Community oncology network

Where OneOncology is headquartered

Location

Headquarters

HQ city
Nashville
HQ country
United States
HQ region
North America

Offices1 record

Markets served

OneOncology business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Management Services Organization (MSO): OneOncology operates as an MSO providing non-clinical administrative and management support to independent medical specialty practices, including oncology and urology. Revenue is generated through partnership arrangements with physician practices that maintain clinical autonomy while gaining access to platform resources, technology, capital, and operational support.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels6 records

OneOncology product offering

Product offering

Core offering

OneOncology is a Management Services Organization (MSO) that partners with independent oncology and urology practices to provide non-clinical administrative, operational, technology, capital, and clinical support while physicians retain clinical autonomy. The platform delivers shared technology, analytics, clinical pathways, research network access, pharmacy and laboratory services, and back-office functions to community-based specialty practices across the United States.

Product overview

OneOncology is a physician-led MSO (Management Services Organization) platform for independent medical specialty practices in oncology, urology, and radiation oncology. The platform operates as a unified ecosystem combining the core OneOncology Platform with multiple integrated modules: OneAnalytics for business intelligence, OneR for clinical research management, Oncology Quality Hub for CMS QCDR compliance and MIPS reporting, ProMPT for precision medicine, Pathways for clinical decision support, OneCommunity for knowledge sharing, and OneCouncil for physician governance. The platform also encompasses acquired brands including United Urology Group, Navigating Care (patient portal), and SunState Medical Specialists. AI capabilities are embedded throughout including patient experience automation, fax intelligence, prior authorization automation, and Databricks-powered analytics.

Differentiator

Problem solved

Functional benefit

Brands

  • Oncology Quality Hub: CMS-approved Qualified Clinical Data Registry (QCDR) platform that supports partner practices in achieving MIPS performance and quality reporting requirements.
  • OneR (OneOncology Research Network)
  • SunState Medical Specialists

Products and services

  • OneOncology Platform Physician-led national platform providing equity partnership arrangements, clinical resources, technology, capital, and operational support to independent oncology and urology practices while preserving physician clinical autonomy.
  • OneAnalytics Analytics platform pulling from multiple systems to measure financial, operational, and clinical performance, providing user-friendly interfaces for physicians and practice leaders to interact with the data warehouse.
  • OneR (OneOncology Research Network) Clinical research site management organization providing program management, study start-up, contracts and budgets, regulatory, study operations, research finance, research technology, quality, and network site management for community oncology practices.
  • Oncology Quality Hub CMS-approved Qualified Clinical Data Registry providing data-driven insights, clinical quality improvement, value-based care program participation, MIPS performance tracking, and CMS data submission for partner practices.
  • ProMPT (Provider Messaging for Precision Therapies) Precision medicine tool nested in the EMR that helps physicians interpret next-generation sequencing results, view patient testing reports, explore matching FDA-approved precision therapy options, and obtain precision medicine team support at point of care.
  • Clinical Pathways ASCO-certified clinical decision support tools driving evidence-based standardized care, clinical trial prioritization, adherence tracking, and informing strategic initiatives with payors around prior authorizations and value-based contracts.
  • United Urology Group Urology management services organization supporting over 250 providers delivering urology care, genitourinary cancer treatment, radiation oncology, pathology, imaging, and pharmacy services.
  • SunState Medical Specialists Multi-specialty physician group (formerly GenesisCare USA) with over 100 physicians across urology, oncology, and surgical specialties at 104 clinics in Florida, providing advanced radiation therapies, in-house pharmacy and laboratory, interventional radiology, theranostics, and diagnostic imaging.
  • Navigating Care Patient portal and care management platform supporting integrated patient engagement and care coordination for partner practices.
  • OneOncology HIE Integration ONC Health IT certified Health Information Exchange integration supporting EMR data exchange with OncoEMR across healthcare systems.
  • AI Strategy Platform AI-powered capabilities including patient experience automation, fax intelligence with EMR integration, agentic AI for drug prior authorization, ProMPT decision analytics, and Databricks-powered data abstraction and clinical trial matching.

Quantifiable outcome

  • Research network with 15 practices active, 92 trials activated in 2025, 260% increase in trial accruals
  • +2 more outcomes

Companies that use OneOncology

Customer profile

Named customers10 records

Segments3 records

Ideal customer profiles2 records

OneOncology technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration2 records

AI capability7 records

Feature5 records

OneOncology partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core.

  • GenesisCare USA (Florida)coreStrategic or Co-development Partner · 8 October 2025OneOncology acquired GenesisCare USA of Florida and relaunched it as SunState Medical Specialists with 100+ physicians across 104 clinics. The acquisition includes plans for investments in advanced clinical services, technology, and expanding access to specialized care in Florida.
  • United Urology Group (UUG)coreStrategic or Co-development Partner · 20 August 2024United Urology Group, a urology management services organization supporting approximately 250 physicians, partnered with OneOncology in October 2024. The partnership aims to improve urology and cancer care, focusing on complex genitourinary cancers including prostate and bladder cancers. UUG operates as a subsidiary of OneOncology, with CEO Ian Wong transitioning to OneOncology COO.

Scale indicators7 records

Recent moves7 records

Expansion highlights6 records

OneOncology competitors and assessment

Company assessment

Direct peers

  • Astrana Health (formerly Apollo Medical Holdings): Physician-centric MSO/value-based care platform serving independent primary care and specialty groups with delegated risk arrangements — comparable MSO structure, capital-light partnership model, and value-based care orientation across diverse specialties.
  • Agilon Health: Physician-group enablement platform partnering with primary care groups under global capitation; comparable capital-light, MSO-style partnership model providing technology, analytics, and payer contracting infrastructure to independent practices.
  • Florida Cancer Specialists & Research Institute: One of the largest independent community oncology practices in the US, also operates its own research institute and has historically pursued vertical integration including in-house pharmacy and lab — a peer model for large-scale community oncology delivery.
  • Evolent Health: Specialty care value-based care enabler with explicit oncology, cardiology, and musculoskeletal programs serving independent practices and payers — directly comparable in specialty VBC enablement and clinical pathway infrastructure for oncology.
  • The US Oncology Network (McKesson): McKesson subsidiary operating the largest US network of community oncology practices with comparable practice partnership MSO economics, technology stack, clinical pathways, and research services — OneOncology's closest and most direct competitor for both partner practices and pharma research dollars.
  • Privia Health Group: Public physician-enablement MSO platform that partners with independent medical groups across specialties to provide technology, analytics, and population health infrastructure — comparable business model of equity-light, MSO-led multi-specialty practice partnership at scale.

Broad incumbents

  • Humana / CenterWell: Senior-focused integrated care platform with growing oncology and senior primary care offerings including CenterWell Senior Primary Care and specialty pharmacy — broader incumbent increasingly moving into community oncology and value-based cancer care delivery.
  • McKesson Corporation: Owner of US Oncology Network and one of the largest pharma distributors in the US — broad incumbent that competes head-to-head with OneOncology for community oncology practices and offers parallel drug-distribution economics post-OneOncology's Cencora acquisition.

Emerging players

  • Thyme Care: Value-based oncology navigation and care management startup partnering with payers and providers to coordinate cancer care — overlaps with OneOncology's patient navigation, care management, and value-based contract strategy on a smaller, earlier-stage scale.

Others

  • ION Solutions (Cencora): Cencora subsidiary providing group purchasing, technology, and practice support services to community oncology practices — sits inside OneOncology's parent and represents an adjacent oncology practice enablement ecosystem rather than a head-to-head competitor.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat7 records

Key risks7 records

Key highlights7 records

Customer concentration

OneOncology social profiles

Digital presence

OneOncology compliance and trust

Trust signal

Compliance2 records

OneOncology financial estimates

Financial estimate

Revenue estimate

Valuation estimate

OneOncology leadership team

Management profile

Number of profiles

Profiles12 records

OneOncology subsidiaries and ownership

Company hierarchy

Subsidiaries2 records

OneOncology funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

OneOncology M&A and investment

M&A and investment

M&A2 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about OneOncology

What does OneOncology do?

OneOncology is a Management Services Organization (MSO) that partners with independent oncology and urology practices to provide non-clinical administrative, operational, technology, capital, and clinical support while physicians retain clinical autonomy. The platform delivers shared technology, analytics, clinical pathways, research network access, pharmacy and laboratory services, and back-office functions to community-based specialty practices across the United States.

Is OneOncology a public or private company?

OneOncology is a private company. It is classified as corporate owned and is currently operating.

When was OneOncology founded?

OneOncology was founded in 2018. It employs 1,001 to 5,000 people.

Where is OneOncology based?

OneOncology is headquartered in Nashville, United States, in the North America region.

How does OneOncology make money?

One revenue line is on record: management Services Organization (MSO).

Who are OneOncology's main competitors?

Direct peers on record are Astrana Health (formerly Apollo Medical Holdings), Agilon Health, Florida Cancer Specialists & Research Institute, Evolent Health, The US Oncology Network (McKesson) and Privia Health Group. Broad incumbents are Humana / CenterWell and McKesson Corporation. Thyme Care is listed as an emerging player. ION Solutions (Cencora) is listed as an others.

Does OneOncology have an API?

No public API is recorded for OneOncology.

What industry is OneOncology in?

OneOncology's product category is Oncology Practice Management Services. Its primary akta.pro industry code is HLAFABAI, Ambulatory Oncology Centers (Outpatient Chemo/Radiation), with a secondary code of HLAKAFAB, Medical Oncology. Its NAICS code is 62111 and its SIC code is 8011.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Pulse 2.0Cencora: OneOncology Drives 61-Basis-Point Margin Expansion Despite Lower-Margin GLP-1 GrowthCencora reported a 61-basis-point expansion in adjusted gross margin for fiscal Q3 2026, driven by the February acquisition of OneOncology which offset margin pressure from lower-margin GLP-1 drug sales. The company's revenue grew 5.1% to approximately $84.8 billion, while adjusted diluted EPS increased 12% to $4.48. Following these results, Cencora raised its full-year fiscal 2026 adjusted diluted EPS guidance.AInvestCencora says development fully contemplated, affirms EPS guideCencora, Inc. reported fiscal third-quarter 2026 adjusted earnings of $4.48 per share and revenue of $84.8 billion, both surpassing analyst estimates. The company raised its full-year adjusted EPS guidance to $17.75–$17.95, citing strong performance in U.S. Healthcare Solutions and the integration of OneOncology.BioSpaceOneOncology and OpenEvidence Partner to Improve Cancer Care NationwideOpenEvidence and OneOncology announced a partnership to embed OpenEvidence into OneOncology's clinical applications, enabling physicians to access clinical evidence directly in their workflows. The integration is expected to expand to include genomic data and clinical trials matching, with over half of U.S. hematology/oncology physicians already using OpenEvidence.Business Wire BlogOneOncology and OpenEvidence Partner to Improve Cancer Care NationwideOpenEvidence and OneOncology announced a partnership to embed OpenEvidence's AI-powered clinical decision-support platform into OneOncology's clinical applications, enabling physicians at OneOncology partner practices to access medical evidence directly within their workflows. The integration targets community oncology practices serving 1.5 million patients nationwide, where over 50% of US cancer patients receive care, with plans to expand into genomic data and clinical trials matching systems. OpenEvidence, already used by more than half of US hematology/oncology physicians, is deepening its reach in the point-of-care clinical decision support market through this collaboration.ChartmillCencora (NYSE:COR) Shares Tick Up as Fiscal Q3 Results Meet Estimates, Full-Year Guidance AdjustedCencora reported fiscal third-quarter revenue of $84.8 billion, up 5.1% year over year, narrowly missing the $85.16 billion consensus while adjusted EPS of $4.48 beat estimates by nearly 2%. Management raised the lower end of full-year adjusted EPS guidance to $17.75–$17.95, with shares rising about 1.2% in premarket trading following a 4.2% decline the prior week. The beat was attributed partly to the February 2026 acquisition of OneOncology, which contributed to segment growth but also added integration costs.Stock TitanCencora Q3 earnings: revenue up 5.1% to $84.8BCencora, Inc. reported fiscal year 2026 third quarter revenue of $84.8 billion, a 5.1% increase year-over-year, with GAAP diluted EPS of $3.94 and adjusted diluted EPS of $4.48, up 12% from the prior year quarter. The company raised its full-year adjusted diluted EPS guidance to $17.75–$17.95 and completed $1 billion in share repurchases during the quarter. Results were driven by the February 2026 acquisition of OneOncology, which boosted gross profit margins in the U.S. Healthcare Solutions segment, alongside growth in the International Healthcare Solutions segment, while a $102 million reduction in opioid litigation liability provided an additional operating income benefit.TradingViewCOR Stock Down Nearly 18% YTD: Should You Buy, Hold or Sell?Cencora Inc. shares have declined 18% year-to-date after the company lowered its fiscal 2026 revenue growth outlook to 4-6%, primarily due to slower GLP-1 demand and regulatory headwinds, despite raising adjusted EPS guidance. The company continues to expand its specialty pharmaceuticals and oncology services through acquisitions like OneOncology and partnerships in cell and gene therapy logistics. Analysts view the current valuation as attractive given improved profitability metrics and positive earnings estimate revisions.PR NewswireOneR and OneOncology Partner Practice Investigators to Present 23 Abstracts at ASCO 2026Physicians affiliated with OneOncology partner practices and the OneOncology Research Network (OneR) will present 23 abstracts at the 2026 ASCO Annual Meeting in Chicago from May 29 to June 2. The research spans multiple tumor types including lung, breast, gastrointestinal, genitourinary, hematologic malignancies, and rare cancers, covering themes in precision oncology, access and equity in clinical trials, and care delivery innovation through real-world evidence and digital tools. OneR reports having 15 practices active in its network, 92 trials activated in 2025, and a 260 percent increase in trial accruals overall.PR NewswireOneOncology Approved as a 2026 Qualified Clinical Data Registry by the Centers for Medicare & Medicaid ServicesOneOncology's Oncology Quality Hub has been approved by the Centers for Medicare & Medicaid Services as a Qualified Clinical Data Registry for 2026, marking the second consecutive year of this designation. The approval authorizes OneOncology to collect clinical data and report MIPS measures for its partner practices and clinicians across all EMR platforms as part of CMS's Quality Payment Program. Additionally, OneOncology developed a new oncology-specific quality measure for DPYD genetic screening, which CMS approved for use by partner practices in the MIPS program shortly after updated national guidance from the FDA and NCCN.American City Business JournalsOneOncology CEO on what's next after Cencora buyCencora has completed its acquisition of OneOncology in a deal valued at $7.4 billion, bringing the healthcare company under the Cencora umbrella. The article discusses the strategic implications of the transaction and outlines the next steps for the combined entity. Details on how the deal was structured or finalized are reserved for subscribers.